Table 2.
Colon-derived solutes excreted in human urine
| Colon-Derived Solute | Urinary Excretion Rate Colectomy/Control | Detected in Control Patient Urine, % | Detected in Colectomy Urine, % | Previously Identified as Colon-Derived | Plasma Ultrafiltrate Hemodialysis/Control | Urinary Clearance Rate Relative to Creatinine | Free Fraction, % |
|---|---|---|---|---|---|---|---|
| Identified as uremic | |||||||
| Phenylacetylglutamate | 0.18 | 100 | 92 | 319.2 | |||
| Cinnamoylglycine | 0.08 | 100 | 67 | x | 177.3 | ||
| p-Cresol glucuronide | 0.00 | 100 | 8 | x | 171.7 | 5.3±2.1 | 8±5 |
| Phenylacetylthreonine | 0.20 | 94 | 8 | 161.4 | |||
| Phenylacetylserine | 0.14 | 82 | 17 | 126.6 | |||
| Phenylacetylalanine | 0.14 | 100 | 25 | 125.3 | |||
| 4-Acetylphenol sulfate | 0.24 | 94 | 50 | 122.0 | |||
| Phenylacetylmethionine | 0.12 | 82 | 0 | 114.5 | |||
| 6-Hydroxyindole sulfate | 0.08 | 100 | 33 | 83.4 | 18.8±7.2 | 1±0.6 | |
| Phenylacetylhistidine | 0.11 | 100 | 25 | 82.5 | |||
| 3-(3-Hydroxyphenyl) propanoic acid sulfate | 0.04 | 100 | 8 | 77.7 | |||
| Trimethylamine N-oxide | 0.14 | 100 | 100 | x | 59.8 | 1.7±0.6 | 37±7 |
| Indoxyl sulfate | 0.08 | 100 | 100 | x | 52.6 | 18.7±4.6 | 2±0.7 |
| Phenylacetylglutamine | 0.22 | 100 | 100 | x | 46.6 | 3.6±0.6 | 37±5 |
| 2-Oxindole-3-acetate | 0.13 | 100 | 58 | 38.6 | |||
| 3-Hydroxyhippuric acid | 0.04 | 100 | 67 | x | 30.6 | 13.2±8.6 | 25±8 |
| p-Cresol sulfate | 0.01 | 100 | 100 | x | 27.4 | 7±1.2 | 2±0.4 |
| 3-Methoxycatechol sulfate | 0.19 | 100 | 100 | 25.4 | 4.9±1.3 | 8±2 | |
| Thioproline | 0.25 | 76 | 17 | 22.7 | 0.6±0.5 | 3±1 | |
| Indoleacetic acid | 0.11 | 100 | 100 | 18.1 | 8.8±8.2 | 2±0.8 | |
| 2,8-Quinolinediol sulfate | 0.07 | 88 | 25 | 17.4 | |||
| 4-Ethylphenylsulfate | 0.01 | 100 | 50 | x | 16.6 | ||
| Phenol sulfate | 0.23 | 100 | 100 | x | 16.6 | 2.4±0.4 | 7±2 |
| Vanillyl alcohol sulfate | 0.13 | 100 | 83 | 14.2 | 8.1±12.6 | 46±57 | |
| 2-Acetamidophenol sulfate | 0.04 | 100 | 17 | 12.5 | |||
| 2-Aminophenol sulfate | 0.12 | 100 | 75 | x | 11.3 | 0.9±0.3 | 29±18 |
| 4-Methylcatechol sulfate | 0.04 | 100 | 67 | x | 11.1 | 8.4±2.9 | 3±1 |
| Formylanthranilic acid | 0.20 | 100 | 42 | 8.1 | |||
| Azelaic acid | 0.22 | 100 | 67 | 6.3 | 1.7±1.9 | 60±33 | |
| Pyrocatechol sulfate | 0.23 | 100 | 92 | 5.1 | 3.2±0.9 | 9±2 | |
| Gentisic acid | 0.10 | 100 | 67 | 4.8 | |||
| 1,2,3-Benzenetriol sulfatea | 0.17 | 100 | 92 | 4.0 | |||
| 5-Hydroxyhexanoaic acid | 0.12 | 65 | 8 | 2.5 | 0.7±0.3 | 64±49 | |
| Not identified as uremic | |||||||
| CMPF | 0.19 | 59 | 8 | 2.6 | |||
| 3-(3-Hydroxyphenyl) propanoic acid | 0.22 | 59 | 0 | 2.1 | 1.4±0.9 | 11±3 | |
| 5-Androstenediol disulfate | 0.15 | 94 | 50 | 1.5 | |||
| Picolinic acid | 0.16 | 88 | 25 | 1.3 | 0.7±0.3 | 25±7 | |
| N-Methyltaurine | 0.07 | 88 | 0 | 1.3 | |||
| Fructose | 0.20 | 82 | 42 | 0.8 | 0.03±0.02 | 110±49 | |
| 1,2,3-Benzenetriol sulfateb | 0.11 | 88 | 58 | ||||
| 3-Hydroxyphenylacetatic acid | 0.11 | 100 | 33 | ||||
| Indolepropionylglycine | 0.04 | 100 | 8 | ||||
| N-Acetylhistamine | 0.18 | 100 | 75 | ||||
| Piperidine | 0.07 | 100 | 100 | ||||
| Pregnen-diol disulfate | 0.21 | 100 | 75 | ||||
| Triethanolamine | 0.14 | 100 | 92 |
Values are mean±SD unless otherwise stated. Urinary clearance rate relative to creatinine and free fraction are reported if both values could be calculated for at least eight out of 17 control patients. Clearance rates and free fractions are calculated from peak areas measured in different sample matrices and provide only estimates of the extent of secretion and protein binding. Solutes were classified as uremic if the ratio of average plasma ultrafiltrate hemodialysis to average control peak areas was >2.4 with the difference in average peak areas q<0.05. Compound names are those used by the Human Metabolomic Database (47), except for CMPF, which is 3-carboxy-4-methyl-5-propyl-2-furanpropanoate.
Sulfate group on second carbon in 1,2,3-benzenetriol sulfate.
Sulfate group on first carbon in 1,2,3-benzenetriol sulfate.